The Centre for Respiratory Research at McGill University and the Research Institute of the McGill University Health Centre
Category Archives: News
Respiratory Research News from the Meakins-Christie Laboratories and the RESP program of the RI-MUHC. View our latest funding results, faculty and trainee awards, and our research featured in the media.
We would like to take the occasion to remind you that Biosafety Training is mandatory for all laboratory workers. As the training is available online, we encourage those working from home to take advantage of this period, for updating their safety training.
The FRQ will support a new province-wide COVID-19 Biobank. McGill researchers, including Dr. Simon Rousseau, will lead a new task force designed to facilitate and coordinate collection of samples and data from COVID-19 patients across Quebec.
Read the opinion piece co-written by Dr. Faiz Ahmad Khanin the Hill Times – published March 25, 2020 here:
With the arrival of COVID-19, Canada’s health-care system is being tested as never before. Canadian leaders must elicit the assistance of private industry to ensure its continued success, as health-care supplies and equipment are rapidly depleted. A substantial increase in testing for the virus together with significant financial investments in research, aimed at a deeper understanding of the virus and development of a vaccine, should also be top priorities. Solid financial support for all those impacted by the virus will ensure a rapid return to normal once the crisis has abated. Maintaining open communication and collaboration between leaders, the government, and with partners across the board is the key to our ultimate success.
Dr. Alain Gauthier is a Meakins-Christie alumnus. He completed his PhD in 1994 under the supervision of Dr. Peter T Macklem. Read the article in the Ottawa Citizen on how Dr. Gauthier modified a ventilator so that more than one person at a time can be hooked up.
Dr. Salman Qureshi and colleagues from the Critical Care – Infectious Diseases Network in Canada speak to the critical actions needed as we experience this public health crisis.
Read the full new article in the National Post published on March 17, 2020 here:
Canadian leaders can reduce the damage caused by COVID-19 to Canadians and Canadian society by paying close attention to decisions taken in countries currently experiencing severe outbreaks. Strategies to mitigate the spread of the virus amongst the population, minimizing the strain of our healthcare system at any one time, coupled with a sharing of resources across boundaries as the demand for health-care fluctuates, will together play an important role on the ultimate long-term effect of this virus on our society.
Please note that all Monday Research Seminars, our Work-in-Progress seminars, and our annual Meakins-Christie workshop have been postponed until further notice.
For the latest COVID-19 information and updates, please log into the RI PORTAL and select Coronavirus (COVID-19) Information & Updates at the top of the page.
On the RI Portal, you will find information on: – Travel abroad and home isolation – Directives for research at the RI-MUHC – Restricted hospital access information – MUHC Town Hall COVID-19 – Travel advisory – COVID-19 FAQ – COVID-19 HR FAQ – COVID-19 ARD FAQ
The first winner of the Dr. Margaret Becklake Fellowship will be chosen to start his or her fellowship in July 2019
Selection of recipients will be made by a committee consisting of the directors of the MUHC respiratory division, the Meakins-Christie Laboratories and the Respiratory Epidemiology and Clinical Research Unit
DR. MARGARET BECKLAKE: A PIONEERING LEADER IN RESPIRATORY MEDICINE
The Montreal Chest Institute Foundation is proud to honour Dr. Becklake’s legacy and immense contribution in developing generations of respiratory clinicians and researchers by launching the Dr. Margaret Becklake Fellowship. This fellowship will be awarded to at least one trainee in respiratory research every year and will pay her or his salary as s/he conducts research under the supervision of scientists at the Montreal Chest Institute of the McGill University Health Centre.
Recipients will be chosen from low- and middle-income countries as well as from Canadian Indigenous communities. Over the course of her career, Dr. Becklake had a major interest in respiratory health in lower-income countries, including in childhood asthma and occupational lung disease. She conducted research in this area for many years. Dr. Becklake also trained and hosted students in respiratory research from lower-income countries, who then became leaders in research and care in those countries.
Help us train the next generation of researchers and specialists in areas of the world where the need is greatest. Help us share the expertise we have at the Montreal Chest Institute around the globe. Help us continue Dr. Becklake’s legacy.
Dr. Margaret Becklake immigrated to Montreal in 1957 from South Africa. Her impact on respiratory care, research and teaching was profound. With other members of the McGill faculty, she worked on occupational lung disease, an interest she maintained from her early medical career in South Africa. She established the now well-known Respiratory Epidemiology and Clinical Research Unit at McGill and at the Montreal Chest Institute.
Dr. Becklake was renowned for her insistence upon the importance of a clearly stated, relevant research question and more generally for her clarity and insight. She was also unfailingly devoted to her patients and their families. The research unit she founded flourishes today, as it continues to emphasize respiratory research of direct relevance to patients and communities.
Five CIHR Project grants were awarded to Meakins and RECRU members in the Fall 2019 competition. Congratulations to ALL!
Basil Petrof. Co-Applicant: Sabah Hussain. Title: Understanding the basis of diaphragmatic weakness in critical illness. Ranked 1st in the Respiratory System Peer Review Committee!
Maziar Divangahi. Title: Reprogramming HSCs to generate protective trained immunity against TB. Ranked 2nd in the Immunology & Transplantation Peer Review Committee!
Maziar Divangahi. Title: Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection.
Carolyn Baglole. Co-Principal Investigator: Ilan Azuelos. Co-Applicants: Andrea Benedetti, Imed Gallouzi. Title: Prognostic and Therapeutic Utility of Human Antigen R (HuR) in Fibrosis.
Faiz Ahmad Khan. Co-Principal Investigators: Glenda Sandy, Christopher Fletcher, Neil Andersson. Co-Applicants: Marie Rochette, Carmen Sicilia, Dick Menzies, Stephanie Law, Richard Long, Alison Doucet. Title: Community Health Workers in Tuberculosis Prevention & Care Services in Nunavik.